Design and evaluation of oral formulation for apixaban

Non-valvular atrial fibrillation (NVAF) is a common form of cardiac arrhythmia that affects 1–1.5% of adults and roughly 10% of elderly adults with dysphagia. Apixaban is an anticoagulant referred to as a factor Xa inhibitor, which has been shown to reduce the risk of stroke and systemic embolism in...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Chien-Chiao, Chen, Yu-Li, Lu, Ta-Chien, Lee, Catherine, Chang, Yu-Chia, Chan, Yen-Fan, Mathew, Philip, Lin, Xing-Rong, Hsieh, Wen-Rung, Huang, Ting-Yun, Huang, Hsin-Lan, Hwang, Tsong-Long
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391955/
https://www.ncbi.nlm.nih.gov/pubmed/37534003
http://dx.doi.org/10.1016/j.heliyon.2023.e18422

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391955/
https://www.ncbi.nlm.nih.gov/pubmed/37534003
http://dx.doi.org/10.1016/j.heliyon.2023.e18422

Ejemplares similares